[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337348-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337348-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","predictive-preventive-and-personalized-medicine-in-breast-cancer-targeting-the-pi3k-pathway","Predictive, preventive, and personalized medicine in breast cancer - targeting the PI3K pathway","","Breast cancer (BC) is a multifaceted disease characterized by distinct molecular subtypes and varying responses to treatment. In BC, the phosphatidylinositol 3-kinase (PI3K) pathway has emerged as a crucial contributor to development, advancement, and resistance to therapy. This review examines how PI3K pathway knowledge supports predictive, preventive, and personalized medicine, including predictive biomarkers, molecular profiling, preventive targeting strategies, and therapy customization. It also addresses mechanisms of resistance to PI3K inhibitors, the rationale for combination approaches, and the need for further validation through research and clinical trials before translation to practice.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/predictive-preventive-and-personalized-medicine-in-breast-cancer-targeting-the-pi3k-pathway/337348/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/predictive-preventive-and-personalized-medicine-in-breast-cancer-targeting-the-pi3k-pathway/337348.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is the PI3K pathway important in breast cancer?","Question",{"text":63,"@type":64},"The PI3K pathway plays a key role in breast cancer development by regulating processes such as cell growth, survival, metabolism, and motility. Dysregulation of the pathway is linked to disease progression and therapy resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the review connect PI3K biology to predictive and personalized medicine?",{"text":68,"@type":64},"The review highlights predictive biomarkers, such as PIK3CA mutations, and the use of molecular profiling to guide treatment decisions. It also discusses tailoring therapy based on tumor stage, molecular subtypes, and genetic alterations.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges and research needs are discussed for PI3K-targeted strategies?",{"text":72,"@type":64},"Resistance to PI3K inhibitors and related mechanisms limit clinical effectiveness. The review addresses combination therapy considerations and emphasizes that further research and clinical trials are needed to validate approaches and translate them into clinical practice.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337348,1790328570,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Tufail et al. Journal of Translational Medicine (2024) 22:15  \n[https://doi.org/10.1186/s12967-023-04841-w](https://doi.org/10.1186/s12967-023-04841-w)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nPredictive, preventive, and personalized   medicine in breast cancer: targeting the PI3K pathway  \nMuhammad Tufail1 , Jia‑Ju Hu 1, Jie Liang1, Cai‑Yun He 1, Wen‑Dong Wan1, Yu‑Qi Huang 1, Can‑Hua Jiang1,2,3,4, Hong Wu5 and Ning Li 1,2,3,4*  \nAbstract  \nBreast cancer (BC) is a multifaceted disease characterized by distinct molecular subtypes and varying responses to treatment. In BC, the phosphatidylinositol 3‑kinase (PI3K) pathway has emerged as a crucial contributor  \nto the development, advancement, and resistance to treatment. This review article explores the implications  \nof the PI3K pathway in predictive, preventive, and personalized medicine for BC. It emphasizes the identification of predictive biomarkers, such as PIK3CA mutations, and the utility of molecular profiling in guiding treatment deci‑ sions. The review also discusses the potential of targeting the PI3K pathway for preventive strategies and the customi‑ zation of therapy based on tumor stage, molecular subtypes, and genetic alterations. Overcoming resistance to PI3K inhibitors and exploring combination therapies are addressed as important considerations. While this field holds promise in improving patient outcomes, further research and clinical trials are needed to validate these approaches and translate them into clinical practice.  \nKeywords Breast cancer, PI3K pathway, Predictive medicine, Preventive medicine, Personalized medicine  \n*Correspondence: Ning Li[liningoms@csu.edu.cn](liningoms@csu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativeco](http://creativeco)[mmons.org/publicdomain/zero/1.0/](mmons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nTufail et al. Journal of Translational Medicine (2024) 22:15 Page 2 of 37  \nGraphical Abstract  \nIntroduction  \nBreast cancer stands as the prevailing form of cancer among women worldwide, exhibiting the highest incidence rate compared to other types of cancer [1, 2]. This complex and diverse disease is characterized by uncontrolled proliferation and growth of abnormal cells in breast tissue. There are diverse subtypes of BC, each with diverse clinical and molecular features and requiring individualized approaches for diagnosis and treatment [3, 4]. Despite advances in oncology, BC remains a global health challenge, requiring further research and innovative therapies [5].  \nThe PI3K pathway has emerged as a key player in BC development [6, 7]. The PI3K pathway governs a wide range of cellular processes through its signaling mechanism, such as cell growth ","cbCaiuKtMWAmO7Mv","https://ap.wps.com/l/cbCaiuKtMWAmO7Mv","pdf",8449095,37,"English","# Abstract\n# Introduction\n## PI3K pathway in breast cancer\n## Downstream signaling mechanisms\n# Graphical Abstract\n# Full text sections (incomplete in provided excerpt)","[{\"question\":\"Why is the PI3K pathway important in breast cancer?\",\"answer\":\"The PI3K pathway plays a key role in breast cancer development by regulating processes such as cell growth, survival, metabolism, and motility. Dysregulation of the pathway is linked to disease progression and therapy resistance.\"},{\"question\":\"How does the review connect PI3K biology to predictive and personalized medicine?\",\"answer\":\"The review highlights predictive biomarkers, such as PIK3CA mutations, and the use of molecular profiling to guide treatment decisions. It also discusses tailoring therapy based on tumor stage, molecular subtypes, and genetic alterations.\"},{\"question\":\"What challenges and research needs are discussed for PI3K-targeted strategies?\",\"answer\":\"Resistance to PI3K inhibitors and related mechanisms limit clinical effectiveness. The review addresses combination therapy considerations and emphasizes that further research and clinical trials are needed to validate approaches and translate them into clinical practice.\"}]","Predictive, preventive, and personalized medicine in breast cancer - targeting the PI3K pathway | PDF",1790018720,93,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cdde4d69d046980d32de50580771022.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce148ac3a4aa1a0ae20ea9fb3c3e2cc0.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ff364780cb0497f20a16bb5e0eb3519.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c079ce1eb38b24e5c3189d082e89285c.webp",980,1301]